基于King达标理论的运动干预对老年肌少症前期人群肌肉力量的影响研究

注册号:

Registration number:

ChiCTR2500101265 

最近更新日期:

Date of Last Refreshed on:

2025-04-22 18:21:50 

注册时间:

Date of Registration:

2025-04-22 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

基于King达标理论的运动干预对老年肌少症前期人群肌肉力量的影响研究

Public title:

Study on the effect of exercise intervention based on King's standard theory on muscle strength in elderly individuals with pre muscular dystrophy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于King达标理论的运动干预对老年肌少症前期人群肌肉力量的影响研究

Scientific title:

Study on the effect of exercise intervention based on King's standard theory on muscle strength in elderly individuals with pre muscular dystrophy

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

卢澜 

研究负责人:

韦薇 

Applicant:

Lan Lu 

Study leader:

Wei Wei 

申请注册联系人电话:

Applicant telephone:

+86 157 7837 7467

研究负责人电话:

Study leader's
telephone:

+86 138 7710 6226

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

962726592@qq.com

研究负责人电子邮件:

Study leader's E-mail:

15733198@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广西南宁市青秀区双拥路6号

研究负责人通讯地址:

广西南宁市青秀区双拥路6号

Applicant address:

No. 6 Shuangyong Road, Qingxiu District, Nanning City, Guangxi Province

Study leader's address:

No. 6 Shuangyong Road, Qingxiu District, Nanning City, Guangxi Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广西医科大学

Applicant's institution:

Guangxi Medical University

研究负责人所在单位:

广西医科大学第一附属医院

Affiliation of the Leader:

The First Affiliated Hospital of Guangxi Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023-K290-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广西医科大学第一附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Guangxi Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-10-24 00:00:00

伦理委员会联系人:

刘影

Contact Name of the ethic committee:

Ying Liu

伦理委员会联系地址:

广西南宁市青秀区双拥路6号

Contact Address of the ethic committee:

No. 6 Shuangyong Road, Qingxiu District, Nanning City, Guangxi Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 771 535 6557

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广西医科大学第一附属医院

Primary sponsor:

The First Affiliated Hospital of Guangxi Medical University

研究实施负责(组长)单位地址:

广西南宁市青秀区双拥路6号

Primary sponsor's address:

No. 6 Shuangyong Road, Qingxiu District, Nanning City, Guangxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广西

市(区县):

南宁

Country:

China

Province:

Guangxi

City:

Nanning

单位(医院):

广西医科大学第一附属医院

具体地址:

广西南宁市青秀区双拥路6号

Institution
hospital:

The First Affiliated Hospital of Guangxi Medical University

Address:

No. 6 Shuangyong Road, Qingxiu District, Nanning City, Guangxi Province

经费或物资来源:

政府

Source(s) of funding:

Government

研究疾病:

肌少症  

Target disease:

Sarcopenia

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

①探讨基于King的达标理论的有氧联合渐进性抗阻运动干预对老年肌少症前期人群肌肉状态,肌肉力量、躯体功能躯体、运动依从性、运动自我效能及其生活质量的影响,②比较单一抗阻运动与有氧联合抗阻运动,两种不同的运动方案对老年肌少症前期人群肌肉力量的影响的优劣。③丰富国内对老年肌少症前期人群的运动干预方案。  

Objectives of Study:

1. Exploring the effects of aerobic combined progressive resistance exercise intervention based on King's standard theory on the muscle state, muscle strength, physical function, exercise compliance, exercise self-efficacy, and quality of life of elderly individuals with pre sarcopenia. 2.Comparing the effects of single resistance exercise and aerobic combined resistance exercise on muscle strength of elderly individuals with pre sarcopenia. 3.Enrich the domestic exercise intervention program for the pre muscular dystrophy population in the elderly.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

①近期有外伤、骨折或手术史者不宜运动的患者;②恶性肿瘤患者;③患有严重疾病,如:心脑血管疾病、呼吸系统和肝、肾功能衰竭者;④既往有严重精神障碍者。

Exclusion criteria:

1. Patients with a recent history of trauma, fractures, or surgery who are not suitable for exercise; 2.Malignant tumor patients; 3. Individuals with serious illnesses, such as cardiovascular and cerebrovascular diseases, respiratory system and liver/kidney failure; 4.Individuals with severe mental disorders in the past.

研究实施时间:

Study execute time:

From 2022-08-01 00:00:00 To 2025-07-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-10-16 00:00:00 To 2024-11-01 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

45

Group:

Control group

Sample size:

干预措施:

空白,常规护理

干预措施代码:

01

Intervention:

Blank, routine care

Intervention code:

组别:

干预A组

样本量:

45

Group:

Intervention Group A

Sample size:

干预措施:

采用渐进性抗阻运动方案

干预措施代码:

02

Intervention:

Adopting a progressive resistance exercise plan

Intervention code:

组别:

干预B组

样本量:

45

Group:

Intervention Group B

Sample size:

干预措施:

采用基于King的达标理论的有氧联合渐进性抗阻运动干预方案

干预措施代码:

03

Intervention:

Adopting an aerobic combined progressive resistance exercise intervention plan based on King's compliance theory

Intervention code:

组别:

观察组

样本量:

300

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广西 

市(区县):

南宁 

Country:

China

Province:

Guangxi

City:

Nanning

单位(医院):

广西医科大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Guangxi Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广西 

市(区县):

钦州 

Country:

China

Province:

Guangxi

City:

Qinzhou

单位(医院):

钦州市第一人民医院 

单位级别:

三甲 

Institution
hospital:

The First People Hospital of Qinzhou

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广西 

市(区县):

桂林 

Country:

China

Province:

Guangxi

City:

Guilin

单位(医院):

桂林医学院附属医院 

单位级别:

三甲 

Institution
hospital:

The Affiliated Hospital of Guilin Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

简易体能状况评分表

指标类型:

主要指标

Outcome:

Short Physical Performance Battery

Type:

Primary indicator

测量时间点:

测量方法:

包含3个部分:即串联站立测试、步行测试和5次起坐试验

Measure time point of outcome:

Measure method:

指标中文名:

上肢最大握力

指标类型:

主要指标

Outcome:

Maximum grip strength of upper limbs

Type:

Primary indicator

测量时间点:

测量方法:

使用握力计(香山牌EH101电子握力计,中国),静息状态,双手各检测握力3次,测量间隔15秒,取最大握力值。

Measure time point of outcome:

Measure method:

指标中文名:

运动依从性达标率

指标类型:

主要指标

Outcome:

Exercise compliance meets the standard rate

Type:

Primary indicator

测量时间点:

测量方法:

本研究运动依从性达标指:研究对象顺利完成研究周期内运动方案≥80%

Measure time point of outcome:

Measure method:

指标中文名:

《运动自我效能量表》

指标类型:

次要指标

Outcome:

The Self-Efficacy for Exercise Scale

Type:

Secondary indicator

测量时间点:

测量方法:

根据量表赋分测量

Measure time point of outcome:

Measure method:

指标中文名:

《国际体力活动问卷(中文版)》

指标类型:

次要指标

Outcome:

International physical activity questionnaire

Type:

Secondary indicator

测量时间点:

测量方法:

根据量表赋分测量

Measure time point of outcome:

Measure method:

指标中文名:

《生活质量评估量表》

指标类型:

次要指标

Outcome:

12-Item Health Survey

Type:

Secondary indicator

测量时间点:

测量方法:

根据量表赋分测量

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

No

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age >60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由不了解本课题的研究人员,采用便利抽样法,将符合纳入排除标准的受试者分为空白对照组与运动干预组

Randomization Procedure (please state who generates the random number sequence and by what method):

Researchers who are not familiar with this topic used convenience sampling to divide participants who met the inclusion and exclusion criteria into a blank control group and an exercise intervention group

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

No

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

实验完成后6个月内在国家生物信息中心 (https://ngdc.cncb.ac.cn/gsub/)公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

China National center for Bioinformation (https://ngdc.cncb.ac.cn/gsub/) within six months after the trial complete

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用向伦理委员会索取的方法,可在发表论文后索要数据。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Asking organization ethic cimmittee for original data after publication.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-04-22 18:21:46